azd0466
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 16, 2019 (NCT04214093)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05205161 | Phase 1/Phase 2 (Phase 2) | Jul 5, 2022 | AstraZeneca |
| NCT04865419 | Phase 1/Phase 2 (Phase 2) | Jun 11, 2021 | AstraZeneca, University of Texas at Houston |
| NCT04214093 | Phase 1 | Dec 16, 2019 | AstraZeneca |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AstraZeneca | For profit | 3 | 3 | 2 | 2019 |
| University of Texas at Houston | Academic/Hospital | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1